Haleon

Haleon plc
TypePublic limited company
ISINGB00BMX86B70
Industry
Predecessors
Founded18 July 2022; 4 years ago (2022-07-18)
HeadquartersWeybridge, England, United Kingdom
Area served
Worldwide
Key people
  • Manvinder Singh Banga (chairman)
  • Brian McNamara (CEO)
Products
Brands
RevenueDecrease £11,030 million (2025)
Increase £2,412 million (2025)
Increase £1,680 million (2025)
Total assetsDecrease £32,630 million (2025)
Total equityIncrease £16,484 million (2025)
Number of employees
24,000 (2024)
SubsidiariesHaleon Pakistan
Websitewww.haleon.com

Haleon plc is a British multinational consumer healthcare company with headquarters in Weybridge, England. It is one of the largest consumer healthcare businesses in the world, with brands including Sensodyne toothpaste, Panadol and Advil painkillers, and Centrum vitamins. The company was projected to be a global leader in over the counter medicines with a 7.3 per cent market share in 2022.

Haleon was established on 18 July 2022 as a corporate spin-off from GSK. Haleon is listed on the London Stock Exchange and is a component of the FTSE 100, with a secondary listing on the New York Stock Exchange.

History

GSK and Pfizer merged their consumer healthcare businesses in 2019. GSK owned just over two thirds of the joint venture, and Pfizer owned the remainder. Annual sales were around £10 billion across 120 markets in 2020. GSK then announced plans to spin off Haleon in 2022 to give the "tired drugmaker extra focus and firepower by gearing up and hiving off the consumer division," according to Reuters. Unilever offered £50 billion for the business in 2022, which GSK rejected. Nestlé examined the possibility of a bid in conjunction with Reckitt. In October 2023, GSK reduced its ownership in Haleon to 7.4%, and in January 2024 it further reduced its ownership to 4.2%.

In August 2023, Haleon sold its Lamisil antifungal brand to Karo Healthcare AB for £235 million, and in February 2024, Haleon sold its ChapStick lip care brand to Yellow Wood Partners for £401 million.

In March 2024, Pfizer reduced its share in Haleon from 32% to 24% per cent by selling 630 million shares in a public offering.

Further sales followed: in April 2024, Haleon announced that it would close its Sensodyne toothpaste factory in Maidenhead, moving that manufacturing to Slovakia, and it outsourced mouthwash manufacturing to an unrelated company and, in September 2024, the company completed the sale of its non-US nicotine replacement therapy business to Dr. Reddy's Laboratories in a deal worth £458 million.

In March 2025, Pfizer sold its entire stake in Haleon for £2.5 billion ($3.24 billion), exiting the consumer healthcare business it helped create by its 2019 joint venture with GSK.

Operations

Oral health accounted for 28.5 percent of revenue in 2021.

Sir Dave Lewis is chairman, with Brian McNamara as chief executive.

Brands

A selection of Aquafresh toothpaste and toothbrushes produced by Haleon

Current

Brands include:

  • Abreva (Docosanol)
  • Advil (Ibuprofen)
  • alli (Orlistat)
  • Anadin (pain relief)
  • Aquafresh (oral healthcare)
  • Astring-o-Sol (oral healthcare)
  • Be-Total (leader in vitamins market in Italy)
  • Beechams Cold & Flu and Night/Day Nurse (cold and flu treatments)
  • Biotene (oral healthcare)
  • Boost (nutritional)
  • Breathe Right (respiratory)
  • Calpol (fever medicine)
  • Caltrate (bone and joint supplement)
  • Centrum (vitamins and naturals)
  • Cetebe (vitamins and naturals)
  • Chlorhexamed (oral healthcare)
  • Cholinex (analgesics and respiratory tract)
  • Citrucel (gastrointestinal)
  • Clusivol (multivitamins)
    • Clusivol Plus (mutivitamins)
    • Clusivol OB (multivitamins for pregnant and lactating women)
    • Children's Clusivol (multivitamins for children)
  • Coldrex (cold and flu treatment)
  • Commit Lozenge (smoking cessation)
  • Committed Quitters (nicotine replacement)
  • Corega (oral healthcare)
  • Corsodyl (oral healthcare)
  • Crocin (analgesics and respiratory tract)
  • Dr. Best (oral healthcare)
  • Emergen-C
  • ENO (gastrointestinal)
  • Eroxon
  • Eumovate (dermatological)
  • Excedrin
  • Fenistil
  • Fenbid (analgesics and respiratory tract)
  • Fibrosine (constipation relief)
  • Flonase (fluticasone propionate)
  • Foodles (noodles), origin: India
  • Formigran (analgesic/triptan)
  • Grand-PA (headache/toothache/pain and fever)
  • Hinds (dermatological)
  • Imedeen
  • Iodex (pain relief)
  • Iodosan (cold and flu treatment)
  • Junior Horlicks (nutritional)
  • Loviscol (cough suppressant)
  • Macleans (oral healthcare)
  • Maltova (nutritional)
  • Maxinutrition (nutritional)
  • Med-Lemon (hot, cold and flu medication)
  • Medacalm (vitamins and naturals)
  • Nexium Control (esomeprazole)
  • Nicorette (nicotine replacement)
  • Night Nurse (cold and flu remedy)
  • NiQuitin CQ/ Nicoderm CQ/ Nicabate (nicotine replacement)
  • Odol (oral healthcare)
  • Odol-med3 (oral healthcare)
  • Os-cal (vitamins and minerals)
  • Otrivin/Otrivine (xylometazoline)
  • Panadeine (analgesics and respiratory tract)
  • Panadol/Panodil (analgesics and respiratory tract)
  • Parodontax (oral healthcare)
  • Piriton/Piriteze/Pirinase (anti-allergy)
  • Polident (oral healthcare)
  • Poligrip Ultra (oral healthcare)
  • Robikids (kids’ cough medicine)
  • Robitussin (respiratory medicine)
  • Rutinoscorbin (vitamins and naturals)
  • Scott's (vitamins and naturals)
  • Sensodyne (oral healthcare)
  • Shumitect (oral healthcare)
  • Simeco (gastrointestinal)
  • Sinecod (cough medicine)
  • Solpadeine (analgesics and respiratory tract)
  • Stresstabs (stress reliever)
  • Super Poligrip (oral healthcare)
  • Super Wernet's (oral healthcare)
  • Synthol (oral healthcare)
  • Theraflu (Respiratory)
  • TriHEMIC (anemia medicine)
  • Tums (gastrointestinal)
  • Viva (vitamins and naturals), origin: Nepal
  • Voltaren/Voltarol (anti inflammatory)
  • Zovirax (dermatological)

Divested

Notes

  1. ↑ In 1993, Warner Lambert and Wellcome created a joint venture with both companies merging their OTC products into a joint venture, the Wellcome OTC brands such as Calpol and Actifed; Glaxo also made a agreement with Warner Lambert in 1994 for the distribution of Zantac. In 1995, Glaxo and Wellcome merged to form Glaxo Wellcome which saw its OTC joint venture with Warner Lambert to now include Calpol, Actifed, and Zantac. In 1996, Warner Lambert bought out Glaxo Wellcome's stake in the joint venture, this caused Calpol, Actifed, and Zantac to be owned by Warner Lambert in most countries, however Glaxo Wellcome retained their OTC division in select countries such as the Philippines, Indonesia and South Africa. In 2000, Glaxo Wellcome and SmithKline Beecham merged to form GSK, in some countries where Glaxo Wellcome retained their OTC division, the remaining OTC division of Glaxo Wellcome also merged with SmithKline Beecham's OTC.
  2. ↑ Pfizer had previously sold its consumer health division (which had included in its portfolio such brands as Listerine, Benadryl, Visine, Combantrin, Mylanta, Nicorette, Sudafed, Rogaine, Rolaids, and Zantac) to Johnson & Johnson in 2006, but re-entered the consumer health industry when it acquired Wyeth (whose consumer health division had included in its portfolio such brands as Advil, Centrum, ChapStick, Dimetapp, and Robitussin) in 2009. It later sold its consumer health division again to GSK plc.

References

  1. ↑ "Warner-Lambert and Wellcome sign joint venture deal". New York Times. 21 December 1993. Retrieved 29 May 2026.
  2. ↑ "Warner-Lambert Buys Glaxo Drug Venture Stake in U.S., Europe". LA Times. 2 July 1996. Retrieved 29 May 2026.
  3. ↑ "Glaxo and Warner-Lambert to End Joint Venture". New York Times. 4 August 1998. Retrieved 29 May 2026.
  4. ↑ "The Glaxo SmithKline merger". BBC News. 17 January 2000. Retrieved 29 May 2026.
  5. 1 2 Sorkin, Andrew Ross (23 January 2009). "Pfizer said to be closing in on deal for Wyeth". The New York Times. Retrieved 8 May 2023.
  6. 1 2 Saul, Stephanie (27 June 2006). "Johnson & Johnson buys Pfizer unit for $16.6 billion". The New York Times. Retrieved 8 May 2023.
  7. ↑ Hall, Jessica; Krauskopf, Lewis (25 January 2009). "Pfizer to buy Wyeth for $68 billion". Reuters. Retrieved 8 May 2023.
  8. ↑ Sorkin, Andrew Ross; Wilson, Duff (26 January 2009). "Pfizer to acquire Wyeth for $68 billion". The New York Times. Retrieved 8 May 2023.
  9. ↑ "Mergers: Commission approves GlaxoSmithKline's acquisition of Pfizer's Consumer Health Business, subject to conditions". European Commission. Retrieved 29 May 2026.
  10. 1 2 3 4 5 "Annual results 2025" (PDF). Haleon. Retrieved 25 February 2026.
  11. ↑ "Sensodyne-maker Haleon to shut UK plant, 435 jobs to go". Reuters. 30 April 2024. Retrieved 9 February 2025.
  12. ↑ "GSK announces independent Consumer Healthcare company is to be called Haleon". www.gsk.com. 22 February 2022. Archived from the original on 21 February 2023. Retrieved 21 February 2023.
  13. ↑ Ralph, Alex (2 July 2022). "GlaxoSmithKline prepares to get back to basics with historic break-up". The Times. Archived from the original on 5 August 2023. Retrieved 4 July 2022.
  14. 1 2 Cornell, Joe (15 July 2021). "GlaxoSmithKline To Spin-Off Consumer Healthcare Business By Mid-2022". Forbes. Archived from the original on 11 February 2023. Retrieved 10 June 2022.
  15. ↑ "Prospectus" (PDF). GSK plc. p. 15. Archived from the original (PDF) on 1 June 2022. Retrieved 10 June 2022.
  16. 1 2 Shane, Daniel (19 December 2018). "Advil meet Excedrin: Pfizer and GSK are merging their consumer healthcare businesses". CNN. Archived from the original on 6 June 2023. Retrieved 10 June 2022.
  17. ↑ "Haleon Won't Indemnify Pfizer, GSK Over Zantac. Shares Are Up". Barron's. 20 September 2022. Archived from the original on 10 November 2022. Retrieved 17 December 2022.
  18. ↑ Donnellan, Aimee (9 June 2022). "GSK castoff starts life with target on its back". Reuters. Archived from the original on 22 September 2022. Retrieved 10 June 2022.
  19. ↑ Jolly, Jasper (19 January 2022). "Unilever will not increase £50bn offer for GSK consumer arm". The Guardian. Archived from the original on 18 October 2022. Retrieved 10 June 2022.
  20. ↑ "Nestle Eyed Biggest-Ever Deal in Aborted Move for GSK Unit". Bloomberg News. 25 May 2022. Archived from the original on 30 April 2023. Retrieved 10 June 2022.
  21. ↑ "GSK raises $1.1 billion from Haleon stake sale". Reuters. 6 October 2023. Archived from the original on 7 October 2023. Retrieved 9 October 2023.
  22. ↑ "GSK raises $1.24 bln from latest Haleon stake sale". Reuters. 17 January 2024. Retrieved 18 January 2024.
  23. ↑ "Karo Healthcare acquires the Global OTC brand Lamisil® from Haleon". Karo Healthcare. 2 August 2023. Archived from the original on 5 June 2024. Retrieved 5 June 2024.
  24. ↑ "Karo Healthcare completes the acquisition of the rights to the Global OTC brand Lamisil® from Haleon". Karo Healthcare. 1 November 2023. Archived from the original on 5 June 2024. Retrieved 5 June 2024.
  25. ↑ Williams, Holly (25 January 2024). "Haleon offloads ChapStick lip balm brand in £401m deal". The Standard. Archived from the original on 20 February 2024. Retrieved 20 February 2024.
  26. ↑ "Pfizer to cut stake in Sensodyne toothpaste-maker Haleon to 24%". Yahoo Finance. 18 March 2024. Archived from the original on 19 March 2024. Retrieved 19 March 2024.
  27. ↑ Briant, Nathan (30 April 2024). "Sensodyne maker set to cut 435 jobs". BBC News. Archived from the original on 8 May 2024. Retrieved 8 May 2024.
  28. ↑ Mathews, Eva (30 April 2024). "Sensodyne-maker Haleon to shut UK plant, 435 jobs to go". Reuters. Retrieved 8 May 2024.
  29. ↑ "Dr Reddy's Laboratories completes acquisition of Haleon's NRT portfolio". Press Trust of India. Business Standard. 30 September 2024. Archived from the original on 29 October 2024. Retrieved 25 November 2024.
  30. ↑ "Pfizer sells entire Haleon stake for $3.24 billion". Reuters.
  31. ↑ "Pfizer sells entire Haleon stake for £2.5 billion". 19 March 2025.
  32. ↑ "Pfizer offloads Haleon shares in $3.24 billion deal". Profit by Pakistan Today. 19 March 2025. Retrieved 20 March 2025.
  33. ↑ "Update: Proposed demerger of the Consumer Healthcare business from GSK to form Haleon". GSK. 6 January 2022. Archived from the original on 29 March 2023. Retrieved 10 June 2022.
  34. ↑ Kleinman, Mark (3 May 2022). "GSK's £45bn Panadol and Sensodyne-maker Haleon in talks to hire banks". Sky News. Archived from the original on 11 February 2023. Retrieved 10 June 2022.
  35. ↑ "Our Consumer Healthcare Brands". Haleon. Archived from the original on 2 August 2023. Retrieved 19 July 2022.
  36. ↑ "Suave Brands Company successfully completes acquisition of #1 lip care brand ChapStick". Cosmetics Design USA. 5 June 2024. Retrieved 21 October 2024.